Ascendis Pharma A ASND Insider Ownership

Updated Oct 5, 2026

Over the trailing 12 months, ASND insiders bought $777,066 worth of shares (3.25K shares) and sold $5.51 million worth (22.7K shares) in open-market trades.

• Counted by insider, open-market buying of ASND stock in the past 12 months came from 2 insiders and selling from 3 insiders.
• Among Ascendis Pharma A's insiders, Jean Jacques Bienaime (Director) was the largest open-market buyer over the past 12 months, purchasing $699,336 of stock (2.9K shares), most recently on August 14, 2026.
• On the selling side, Flemming Steen Jensen (Officer) sold the most Ascendis Pharma A stock on the open market over the past 12 months, $4.64 million (19.46K shares), most recently on May 11, 2026.
• Ascendis Pharma A's latest insider trade on the open market was a sale of 3K shares for $810,570 by Mads Bodenhoff (SVP & PAO) on September 8, 2026.
• Apart from open-market trades, ASND insiders acquired 3K shares through option exercises and conversions in the past 12 months.
• Business Quant data puts insider holdings in ASND at 11.27K shares across insiders' latest Form 4 filings.
• ASND's insiders hold all 11.27K shares directly, in their own names, with no indirect holdings.
• The insider holdings in Ascendis Pharma A belong to 3 insiders who have reported on Form 4 within the past two years.
• Ascendis Pharma A's top three insider holders by shares held are Scott Thomas Smith (EVP & Chief Financial Officer, 4.37K shares), Lars Holtug (Director, 4K shares) and Jean Jacques Bienaime (Director, 2.9K shares).
• The largest insider, Scott Thomas Smith, holds 38.76% of ASND's insider total.
• In the last 12 months, 8 Form 4 filings with transactions in ASND stock came from 5 insiders.
• Insider figures for ASND include Form 4 filings through September 10, 2026.